Ceylon Hospitals PLC (COSE:CHL.N0000)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Ceylon Hospitals Ratios and Metrics
Market cap in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,867 | 9,548 | 5,026 | 4,150 | 4,172 | 3,354 | |
Market Cap Growth | 47.86% | 89.97% | 21.11% | -0.53% | 24.41% | 0.76% |
Enterprise Value | 10,726 | 10,687 | 6,764 | 7,138 | 6,323 | 3,878 |
Last Close Price | 62.00 | 58.92 | 30.39 | 27.83 | 30.19 | 22.72 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.92 | 10.04 | 7.70 | 9.95 | 7.30 | 3.41 |
PS Ratio | 0.90 | 0.87 | 0.53 | 0.45 | 0.53 | 0.43 |
PB Ratio | 0.77 | 0.75 | 0.42 | 0.47 | 0.49 | 0.41 |
P/TBV Ratio | 0.83 | 0.80 | 0.45 | 0.51 | 0.54 | 0.44 |
P/FCF Ratio | 10.73 | 10.38 | 6.23 | - | - | 8.48 |
P/OCF Ratio | 5.89 | 5.70 | 3.61 | 2.40 | 38.55 | 2.23 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.98 | 0.97 | 0.72 | 0.78 | 0.80 | 0.50 |
EV/EBITDA Ratio | 4.85 | 5.21 | 4.71 | 6.96 | 4.86 | 2.24 |
EV/EBIT Ratio | 7.85 | 7.82 | 7.51 | 12.25 | 6.92 | 2.79 |
EV/FCF Ratio | 11.66 | 11.62 | 8.38 | - | - | 9.81 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.18 | 0.18 | 0.21 | 0.40 | 0.37 | 0.27 |
Debt / EBITDA Ratio | 1.01 | 1.01 | 1.56 | 3.10 | 2.21 | 1.23 |
Debt / FCF Ratio | 2.44 | 2.44 | 3.05 | - | - | 5.70 |
Net Debt / Equity Ratio | 0.00 | 0.00 | 0.06 | 0.26 | 0.23 | -0.01 |
Net Debt / EBITDA Ratio | -0.03 | -0.03 | 0.53 | 2.24 | 1.48 | -0.05 |
Net Debt / FCF Ratio | -0.06 | -0.06 | 0.94 | -38.29 | -0.91 | -0.24 |
Asset Turnover | 0.59 | 0.59 | 0.57 | 0.63 | 0.59 | 0.66 |
Inventory Turnover | 5.44 | 5.44 | 5.37 | 4.38 | 3.34 | 4.20 |
Quick Ratio | 1.00 | 1.00 | 0.87 | 0.70 | 0.77 | 1.38 |
Current Ratio | 1.47 | 1.47 | 1.29 | 1.18 | 1.66 | 1.94 |
Return on Equity (ROE) | 8.50% | 8.50% | 6.98% | 5.24% | 7.77% | 14.31% |
Return on Assets (ROA) | 4.62% | 4.62% | 3.40% | 2.50% | 4.24% | 7.33% |
Return on Invested Capital (ROIC) | 8.03% | 8.05% | 5.73% | 3.72% | 6.03% | 14.29% |
Return on Capital Employed (ROCE) | 8.40% | 8.40% | 5.70% | 4.60% | 7.50% | 12.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 9.64% | 9.96% | 12.98% | 10.05% | 13.71% | 29.29% |
FCF Yield | 9.32% | 9.63% | 16.06% | -1.45% | -50.58% | 11.79% |
Dividend Yield | 1.77% | 1.87% | 3.29% | 1.80% | 1.91% | 5.50% |
Payout Ratio | 17.62% | 17.62% | 14.46% | 19.84% | 29.62% | 11.03% |
Buyback Yield / Dilution | - | - | -16.41% | -6.23% | -0.02% | - |
Total Shareholder Return | 1.77% | 1.87% | -13.12% | -4.44% | 1.89% | 5.50% |